| # | Drug | Count |
|---|---|---|
| 0 | IBUPFROFEN | 52 |
| 1 | IBUPROFEN | 52 |
| 2 | IBUPROFEN 200 MG | 52 |
| 3 | IBUPROFEN 200MG | 52 |
| 4 | IBUPROFEN CAPSULE | 52 |
| 5 | IBUPROFEN CAPSULES 200 MG | 52 |
| 6 | IBUPROFEN ORAL | 52 |
| 7 | IBUPROFEN TABLET, FILM COATED | 52 |
| 8 | IBUPROFEN TABLET, FILM-COATED | 52 |
| 9 | IBUPROFEN TABLETS USP, 200MG | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 14 | 0.0051 |
| 1 | PAMIDRONATE DISODIUM | 15 | 0.0044 |
| 2 | ELOSULFASE ALFA | 13 | 0.0024 |
| 3 | GALSULFASE | 9 | 0.0023 |
| 4 | BUROSUMAB | 12 | 0.0018 |
| 5 | CYSTEAMINE HYDROCHLORIDE | 1 | 0.0015 |
| 6 | ZOLEDRONIC ACID | 48 | 0.0012 |
| 7 | CYSTEAMINE BITARTRATE | 1 | 0.0010 |
| 8 | ALDESLEUKIN | 1 | 0.0008 |
| 9 | ANTIHEMOPHILIC FACTOR HUMAN | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 77 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 29 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 25 |
| 3 | Vitamin D [EPC] | 19 |
| 4 | Janus Kinase Inhibitor [EPC] | 18 |
| 5 | Corticosteroid [EPC] | 16 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 7 | Interleukin-23 Antagonist [EPC] | 15 |
| 8 | Proton Pump Inhibitor [EPC] | 10 |
| 9 | Vitamin C [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 25 | 0.0019 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Interleukin-23 Antagonist [EPC] | 15 | 0.0001 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Janus Kinase Inhibitor [EPC] | 18 | 0.0001 |
| 9 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |